CD45(+)CD33(low)CD11b(dim) myeloid-derived suppressor cells suppress CD8(+) T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer.
CD45(+)CD33(low)CD11b(dim) myeloid-derived suppressor cells suppress CD8(+) T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer.
复制标题
DOI:
10.1038/s41419-018-0803-7
复制
发表时间:
2018-07-09
影响因子:
9
通讯作者:
Zhuang Y
中科院分区:
文献类型:
--
作者:
Mao FY;Zhao YL;Lv YP;Teng YS;Kong H;Liu YG;Wu XL;Hao CJ;Chen W;Duan MB;Han B;Ma Q;Wang TT;Peng LS;Zhang JY;Cheng P;Su CY;Fu XL;Zou QM;Guo G;Guo XL;Zhuang Y
Myeloid-derived suppressor cells (MDSCs) are a prominent component of the pro-tumoral response. The phenotype of and mechanisms used by MDSCs is heterogeneous and requires more precise characterization in gastric cancer (GC) patients. Here, we have identified a novel subset of CD45+CD33lowCD11bdim MDSCs in the peripheral blood of GC patients compared to healthy individuals. CD45+CD33lowCD11bdim MDSCs morphologically resembled neutrophils and expressed high levels of the neutrophil marker CD66b. Circulating CD45+CD33lowCD11bdim MDSCs effectively suppressed CD8+ T cells activity through the inhibition of CD8+ T cell proliferation and interferon-γ (IFN-γ) and granzyme B (GrB) production. The proportion of CD45+CD33lowCD11bdim MDSCs also negatively correlated with the proportion of IFN-γ+CD8+ T cell in the peripheral blood of GC patients. GC patient serum-derived IL-6 and IL-8 activated and induced CD45+CD33lowCD11bdim MDSCs to express arginase I via the PI3K-AKT signaling pathway. This pathway contributed to CD8+ T cell suppression as it was partially rescued by the blockade of the IL-6/IL-8-arginase I axis. Peripheral blood CD45+CD33lowCD11bdim MDSCs, as well as IL-6, IL-8, and arginase I serum levels, positively correlated with GC progression and negatively correlated with overall patient survival. Altogether, our results highlight that a subset of neutrophilic CD45+CD33lowCD11bdim MDSCs is functionally immunosuppressive and activated via the IL-6/IL-8-arginase I axis in GC patients.
登录
查看更多内容
影响因子:
6.4
作者:
Rotondo, Rita;Barisione, Gaia;Barbieri, Ottavia
通讯作者:
Barbieri, Ottavia
影响因子:
20.3
作者:
Movahedi, Kiavash;Guilliams, Martin;Van Ginderachter, Jo A.
通讯作者:
Van Ginderachter, Jo A.
影响因子:
20.3
作者:
Munder, M;Mollinedo, F;Modolell, M
通讯作者:
Modolell, M
影响因子:
3.7
作者:
SANDER, B;CARDELL, S;MOLLER, E
通讯作者:
MOLLER, E
影响因子:
17.1
作者:
Wu H;Zhen Y;Ma Z;Li H;Yu J;Xu ZG;Wang XY;Yi H;Yang YG
通讯作者:
Yang YG